Neovascular Macular Degeneration: Clinical Trials

1 trial for Neovascular Macular Degeneration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Neovascular Macular Degeneration: new trials by email Literature Review of Neovascular Macular Degeneration trials Research Report on Neovascular Macular Degeneration

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aflibercept in Polypoidal Choroidal Vasculopathy
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Visudyne - Neovascular Macular Degeneration
Phase 4CompletedBayer3332014-05-292020-12-02

Interventions

Verteporfin (1)  ·  aflibercept (1)

Sponsors

Bayer (1)

Countries

Australia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Japan (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)

Results publications

PMID 29801063, PMID 41903075